rs151294087
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001080.3(ALDH5A1):c.1474G>A(p.Val492Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000141 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH5A1 | NM_001080.3 | c.1474G>A | p.Val492Ile | missense_variant | Exon 10 of 10 | ENST00000357578.8 | NP_001071.1 | |
ALDH5A1 | NM_170740.1 | c.1513G>A | p.Val505Ile | missense_variant | Exon 11 of 11 | NP_733936.1 | ||
ALDH5A1 | NM_001368954.1 | c.1330G>A | p.Val444Ile | missense_variant | Exon 9 of 9 | NP_001355883.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000167 AC: 42AN: 251490Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135918
GnomAD4 exome AF: 0.000126 AC: 184AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.000117 AC XY: 85AN XY: 727248
GnomAD4 genome AF: 0.000289 AC: 44AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74436
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 25, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Succinate-semialdehyde dehydrogenase deficiency Benign:1Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 01, 2025 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 18, 2022 | Variant summary: ALDH5A1 c.1474G>A (p.Val492Ile) results in a conservative amino acid change located in the aldehyde dehydrogenase domain (IPR015590) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 251490 control chromosomes, predominantly at a frequency of 0.0011 within the African or African-American subpopulation in the gnomAD database. To our knowledge, no occurrence of c.1474G>A in individuals affected with Succinic Semialdehyde Dehydrogenase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. Two classified the variant as VUS and the other classified it as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.1474G>A (p.V492I) alteration is located in exon 10 (coding exon 10) of the ALDH5A1 gene. This alteration results from a G to A substitution at nucleotide position 1474, causing the valine (V) at amino acid position 492 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at